Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals

CAS OpenIR > 2024年度论文

	Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals
发表期刊	FRONTIERS IN IMMUNOLOGY
	2024-11
卷号	15
	Zhang, Qi; Xia, Chengxiang; Weng, Qitong; Zhang, Leqiang; Wang, Yao; Liu, Yanhong; Zheng, Xiujuan; Lin, Yunqing; Chen, Yi; Shen, Yiyuan; Qi, Hanmeng; Liu, Lijuan; Zhu, Yanping; Zhang, Min; Huang, Dehao; Hu, Fangxiao; Zhang, Mengyun; Zeng, Hui; Wang, Jinyong; Wang, Tongjie
关键词	NATURAL-KILLER-CELLS HLA-E RECEPTORS EXPRESSION TRANSPLANTATION IMMUNOTHERAPY THERAPEUTICS PERSISTENCE CD94/NKG2A DISRUPTION
文献类型	期刊论文
条目标识符	http://ir.ioz.ac.cn/handle/000000/16202
专题	2024年度论文
推荐引用方式 GB/T 7714	Zhang, Qi,Xia, Chengxiang,Weng, Qitong,et al. Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals[J]. FRONTIERS IN IMMUNOLOGY,2024,15.
APA	Zhang, Qi.,Xia, Chengxiang.,Weng, Qitong.,Zhang, Leqiang.,Wang, Yao.,...&Wang, Tongjie.(2024).Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals.FRONTIERS IN IMMUNOLOGY,15.
MLA	Zhang, Qi,et al."Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals".FRONTIERS IN IMMUNOLOGY 15(2024).